Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Chutes and Ladders
Biotech
FDA gene therapy regulator steps down from leadership role
Acting CBER Director Karim Mikhail will oversee the Office of Therapeutic Products until a new permanent leader is found.
Darren Incorvaia
Jun 30, 2026 10:36am
EMD Serono taps in new commercial strategy head—Chutes & Ladders
Jun 26, 2026 8:30am
Sanofi replaces R&D chief as new CEO seeks to kickstart pipeline
Jun 22, 2026 3:48am
Perrigo CEO ousted over ‘personal conduct’—Chutes & Ladders
Jun 12, 2026 8:30am
AstraZeneca adds FDA cell and gene veteran—Chutes & Ladders
Jun 5, 2026 8:30am
Allogene swaps in CMO as new chief exec—Chutes & Ladders
May 29, 2026 8:30am
